Firms

Magnetic Ventures

Magnetic Ventures

Boston, Massachusetts, United States · Miami, Florida, United States · Research Triangle Park, North Carolina, United States

US venture capital firm founded by Christine Aylward in 2018, backing companies at the intersection of deep technology and life sciences. Magnetic Ventures invests in AI, machine learning, multiomics, drug discovery, precision medicine and technology-enabled healthcare, typically entering at seed or Series A with initial checks of $1–6 million. Its current offices are in Boston, Miami and Research Triangle Park. The team comprises a founder and managing partner, two venture partners and three advisers. Portfolio companies include Proxima Bio, Weave Bio, Relation Therapeutics, Deep Genomics, Transition Bio and Gilgamesh Pharmaceuticals. Magnetic Ventures Management, LLC reports Funds I and II; reported asset values and fundraising targets are distinct from completed fund closings. This US healthcare firm is separate from Berlin infrastructure investor Magnetic Capital.

Founded
2018
Type
Venture capital

Funds2

  • Magnetic Ventures Fund I, L.P.—
  • Magnetic Ventures Fund II, L.P.—

Team

$75M$50K – $150MNew York, New York

Operations and support

Christine AylwardChristine AylwardFounder and Managing Partner
Jillian ShawJillian ShawVenture Partner
Jim WeissJim WeissAdvisor
Umut EserUmut EserVenture Partner

Co-investing

DCVC
Jason Pontin
NVentures
ARCH Venture Partners
Bristol Myers Squibb

Investments